Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
MeiLan K. Han, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, Christine E. Jones, Sally Kilbride, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert A. Wise, Ian P. Naya, Dave Singh. Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis. ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020

Member's Comments

No comment yet.

Related content which might interest you: Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in IIPs: Secondary analysis of SETUP trial Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2011; 39: 223-224 Year: 2012 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2012; 39: 223-224 Year: 2012 Umeclidinium/vilanterol in preventing clinically important deterioration (CID) in COPD and impact of baseline disease severity: the EMAX trial Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Prognostic assessment in COPD without lung function: the B-AE-D indices Source: Eur Respir J 2016; 47:1635-1644 Year: 2016 Prognostic features of disability in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 57s Year: 2004 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) in patients with moderate COPD: Results from the CRYSTAL study Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial Source: International Congress 2018 – COPD management Year: 2018 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Prognostic values of biomarkers in COPD Source: Annual Congress 2013 –Natural history of COPD: novel aspects Year: 2013 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016